News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Nelson Dusetti: Guiding treatment decisions for operable and metastatic patients with PDAC
YouTube.com
Oct 16, 2024, 14:54

Nelson Dusetti: Guiding treatment decisions for operable and metastatic patients with PDAC

Nelson Dusetti posted on X:

“We discuss here the dual resistance to mFOLFIRINOX and gemcitabine, the role of transcriptomic signatures in reducing toxicity and guiding treatment decisions for operable and metastatic patients reinforcing their potential for personalized treatment.

Reply to the Letter to the Editor ‘AI-assisted personalized adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma’ by Y. Shimazu

Authors: N. Fraunhoffer, P. Hammel, J. Iovanna, N. Dusetti.”

Nelson Dusetti: Guiding treatment decisions for operable and metastatic patients with PDAC

Nelson Dusetti, Scientific Director of the company Predicting Med (CSO) and Chair of TRANSLATE-IT CRCM. He is also research director at INSERM. He is the Head of the Department of Translational Research and Innovative Therapies at CRCM.

cancer Gemcitabine J. Iovanna mFOLFIRINOX N. Dusetti N. Fraunhoffer OncoDaily Oncology P. Hammel
Special Coverage
Science
Jan 16, 2025, 14:16
Cecilia Pompili: Terrific paper from Dr Melinda L. Hsu on unmet needs and QoL in NSCLC survivors
Career
Jan 16, 2025, 14:12
St. Jude Global Critical Care team is looking for a Clinical Research Scientist
Career
Jan 16, 2025, 14:06
Antonio Gualberto: I’m starting a new position as Global Head, Due Diligence Oncology at EMD Serono
Blog
Jan 16, 2025, 13:56
Miriam Mutebi: Stories like Claire’s haunt us as clinicians
Blog
Jan 16, 2025, 13:39
NHS England starts sending bowel cancer screening tests to over-50s
Blog
Jan 16, 2025, 13:38
Justin Stebbing: Princess of Wales "in remission" from cancer
Career
Jan 16, 2025, 13:33
Daniel Mckenzie: Started my role at KidzCan Zimbabwe as an Executive Director
Science
Jan 16, 2025, 13:29
Chang-il Hwang: How organoid technology is transforming pancreatic cancer research
Blog
Jan 16, 2025, 13:22
Prisca Githuka: I rang the bell at the finish line after 10 years of being on Cancer hormonal treatment
Blog
Jan 16, 2025, 13:21
Akhil Santhosh: Prevention of dermatologically adverse events with amivantamab combinations
Radiotherapy
Jan 16, 2025, 13:14
What Is Palliative Radiotherapy and How It Works? Pros and Cons
Opinion
Jan 16, 2025, 13:08
Amol Akhade: OS difference in first line Cdk inhibitors plus AI, amongst Palbociclib, Ribociclib and abemaciclib in MBC